Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents
A new series of N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamide and phenylacetamide derivatives ( 1a– 1n, 2a– 2n) were synthesized and evaluated for antibacterial and antifungal activities against Staphylococcus aureus, Bacillus subtilis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia c...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 15; no. 5; pp. 2032 - 2044 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
01.03.2007
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A new series of
N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamide and phenylacetamide derivatives (
1a–
1n,
2a–
2n) were synthesized and evaluated for antibacterial and antifungal activities against
Staphylococcus aureus,
Bacillus subtilis,
Klebsiella pneumoniae,
Pseudomonas aeruginosa,
Escherichia coli,
Candida albicans, and their drug-resistant isolates. Microbiological results indicated that the compounds possessed a broad spectrum of activity against the tested microorganisms at MIC values between 500 and 1.95
μg/ml. Benzamide derivative
1d exhibited the greatest activity with MIC values of 1.95, 3.9, and 7.8
μg/ml against drug-resistant
B. subtilis,
B. subtilis, and
S. aureus, respectively.
A new series of
N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamide and phenylacetamide derivatives (
1a–
1n,
2a–
2n) were synthesized and evaluated for antibacterial and antifungal activities against
Staphylococcus aureus,
Bacillus subtilis,
Klebsiella pneumoniae,
Pseudomonas aeruginosa,
Escherichia coli,
Candida albicans, and their drug-resistant isolate. Microbiological results indicated that the compounds possessed a broad spectrum of activity against the tested microorganisms at MIC values between 500 and 1.95
μg/ml. Benzamide derivative
1d exhibited the greatest activity with MIC values of 1.95, 3.9, and 7.8
μg/ml against drug-resistant
B. subtilis,
B. subtilis, and
S. aureus, respectively. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2006.12.035 |